Editas is partnering its CRISPR platform with Genevant’s LNP technology to develop novel gene editing medicines in a deal ...

MangoRx said it “strongly refutes” claims made by Eli Lilly that it improperly copied blockbuster weight-loss medicines for ...

Monday’s lawsuits from Eli Lilly are the first to be filed by the pharma since the regulator officially removed tirzepatide ...

The IOF highlights the importance of collaborative efforts in treating osteoporosis, ensuring appropriate care globally.

Mangoceuticals, Inc. (MGRX), a provider of men's health and wellness products, announced on Tuesday that its Board has initiated a ...

Crunchtime's AI forecasting is included in both the Inventory Management and Labor & Scheduling solutions. To learn more about Crunchtime AI forecasting, visit ...

Dallas, Texas, Oct. 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on ...

Lilly has already sued more than two dozen medical spas, wellness centers and compounding pharmacies for selling products ...

Mangoceuticals, Inc. (NASDAQ: MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling men's health and wellness products ...

Mangoceuticals (MGRX) said it strongly refutes claims made in a lawsuit filed by Eli Lilly (LLY) over a compounded version of ...

MangoRx remains committed to its mission and plans to continue to enhance patient care by offering new and innovative ...

Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, ...